CurrentEndo coverage · page 47 of 55

Diabetes, Obesity and Metabolism

Briefs 1,841–1,880 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab3 Nov 2023
Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial
Randomized controlled trialTechnology
Diabetes Obes Metab3 Nov 2023
Sex‐specific causality of MRI ‐derived body compositions on glycaemic traits: Mendelian randomization and observational study
Cohort studyT2D & other
Diabetes Obes Metab31 Oct 2023
Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics
Cohort studyTechnology
Diabetes Obes Metab26 Oct 2023
In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank
Cohort studyT2D & other
Diabetes Obes Metab25 Oct 2023
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial
Randomized controlled trialT1D
Diabetes Obes Metab23 Oct 2023
Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults
Cohort studyLipids & liver
Diabetes Obes Metab23 Oct 2023
Ultra‐rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double‐blind phase 3 study
Randomized controlled trialT1D
Diabetes Obes Metab23 Oct 2023
Impact of physical fitness and exercise training on subcutaneous adipose tissue beiging markers in humans with and without diabetes and a high‐fat diet‐fed mouse model
Mechanistic studyT2D & other
Diabetes Obes Metab23 Oct 2023
Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab23 Oct 2023
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab22 Oct 2023
5‐Year simulation of diabetes‐related complications in people treated with tirzepatide or semaglutide versus insulin glargine
Research articleT2D & other
Diabetes Obes Metab20 Oct 2023
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
Secondary analysisT2D & other
Diabetes Obes Metab20 Oct 2023
Impact of a dual glucose‐dependent insulinotropic peptide/ glucagon‐like peptide ‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab19 Oct 2023
Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study
Cohort studyT2D & other
Diabetes Obes Metab18 Oct 2023
Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials
Secondary analysisT2D & other
Diabetes Obes Metab17 Oct 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52‐week randomized controlled clinical trial
Randomized controlled trialDiabetes in pregnancy
Diabetes Obes Metab17 Oct 2023
Metabolic syndrome, genetic susceptibility, and risk of chronic obstructive pulmonary disease: The UK Biobank Study
Cohort study
Diabetes Obes Metab16 Oct 2023
Societal health and economic burden of cardiovascular diseases in the population with type 2 diabetes in Qatar. A 10 ‐year forecasting model
Research articleT2D & other
Diabetes Obes Metab12 Oct 2023
Types of diabetes during pregnancy and risk of depression and anxiety in offspring from childhood to young adulthood
Cohort studyDiabetes in pregnancy
Diabetes Obes Metab12 Oct 2023
Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China
Meta-analysisT2D & other
Diabetes Obes Metab12 Oct 2023
Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance
Case-control studyT2D & other
Diabetes Obes Metab12 Oct 2023
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus
Meta-analysisT2D & other
Diabetes Obes Metab12 Oct 2023
Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials
Meta-analysisTechnology
Diabetes Obes Metab12 Oct 2023
Metabolically healthy obese individuals are still at high risk for diabetes: Application of the marginal structural model
Cohort studyObesity
Diabetes Obes Metab12 Oct 2023
Time trends towards earlier puberty in boys and girls with type 1 diabetes: Insights from the German Diabetes Prospective Follow‐up (DPV) registry, 2000 to 2021
Cohort studyT1D
Diabetes Obes Metab11 Oct 2023
Bone marrow metabolism is affected by body weight and response to exercise training varies according to anatomical location
Research articleObesity
Diabetes Obes Metab10 Oct 2023
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis
Meta-analysisT2D & other
Diabetes Obes Metab9 Oct 2023
Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
Cohort studyObesity
Diabetes Obes Metab9 Oct 2023
The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses
Cohort studyT2D & other
Diabetes Obes Metab9 Oct 2023
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion
Randomized controlled trialT1D
Diabetes Obes Metab5 Oct 2023
The relationship between glycated haemoglobin and blood glucose‐lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II
Cohort studyT2D & other
Diabetes Obes Metab5 Oct 2023
The impact of type 2 diabetes and glycaemic control on mortality and clinical outcomes in hospitalized patients with COVID ‐19 in the capital region of Denmark
Cohort studyT2D & other
Diabetes Obes Metab4 Oct 2023
Glycaemic control, body weight, and safety of tirzepatide versus dulaglutide by baseline glycated haemoglobin level in Japanese patients with type 2 diabetes: A subgroup analysis of the SURPASS J‐mono study
Secondary analysisT2D & other
Diabetes Obes Metab3 Oct 2023
Incremental burden on health‐related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non‐institutionalized people with diabetes aged 65 years and older
Cross-sectional studyT2D & other
Diabetes Obes Metab1 Oct 2023
Differential effect of interventions in patients with prediabetes stratified by a machine learning‐based diabetes progression prediction model
Secondary analysisT2D & other
Diabetes Obes Metab1 Oct 2023
Multi‐tissue transcriptome‐wide association study reveals susceptibility genes and drug targets for insulin resistance‐relevant phenotypes
Research articleT2D & other
Diabetes Obes Metab25 Sep 2023
Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys
Cross-sectional studyT2D & other
Diabetes Obes Metab25 Sep 2023
Comparison of Control‐IQ and open‐source AndroidAPS automated insulin delivery systems in adults with type 1 diabetes: The CODIAC study
Cohort studyTechnology
Diabetes Obes Metab25 Sep 2023
Global burden of diabetes mellitus from 1990 to 2019 attributable to dietary factors: An analysis of the Global Burden of Disease Study 2019
Secondary analysisT2D & other
Diabetes Obes Metab21 Sep 2023
Efficacy and safety of adding once‐weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients ( AWARD‐CHN3 ): A randomized, double‐blind, placebo‐controlled, phase III trial
Randomized controlled trialT2D & other

All 2,200 Briefs in ExploreShowing Briefs 1,841–1,880 of 2,200, newest first